Ambrx Biopharma Inc(NASDAQ:AMAM) 
Ambrx is a clinical stage biopharmaceutical company using an expanded genetic code technology platform to discover and develop next generation antibody drug conjugates (ADCs) and other engineered therapies to modulate the immune system.
Website: https://ambrx.com/
Founded: 2003
Sector: Professional, Scientific, and Technical Services
Industry: Research and Development in Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2023-09-08
P
O 12.74
H 12.79
L 12.10
C 12.21
V 224,961
10EMA 12.21
20EMA 12.21
60EMA 12.21
120EMA 12.21
250EMA 12.21